These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 8143100)
21. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient. Walsh TJ; Schimpff SC Schweiz Med Wochenschr Suppl; 1983; 14():58-63. PubMed ID: 6361993 [TBL] [Abstract][Full Text] [Related]
22. Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center. Huang YC; Wu PF; Lin YT; Wang FD J Microbiol Immunol Infect; 2019 Apr; 52(2):304-311. PubMed ID: 30097388 [TBL] [Abstract][Full Text] [Related]
23. Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse. Hanna H; Afif C; Alakech B; Boktour M; Tarrand J; Hachem R; Raad I Infect Control Hosp Epidemiol; 2004 Aug; 25(8):646-9. PubMed ID: 15357155 [TBL] [Abstract][Full Text] [Related]
24. Invasive bacterial infections in a pediatric oncology unit in a tertiary care center. Trehan A; Totadri S; Gautam V; Bansal D; Ray P Indian J Cancer; 2014; 51(4):428-31. PubMed ID: 26842149 [TBL] [Abstract][Full Text] [Related]
25. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. Cruciani M; Rampazzo R; Malena M; Lazzarini L; Todeschini G; Messori A; Concia E Clin Infect Dis; 1996 Oct; 23(4):795-805. PubMed ID: 8909847 [TBL] [Abstract][Full Text] [Related]
27. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. Klastersky J; Zinner SH; Calandra T; Gaya H; Glauser MP; Meunier F; Rossi M; Schimpff SC; Tattersall M; Viscoli C Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S35-45. PubMed ID: 3280326 [TBL] [Abstract][Full Text] [Related]
28. Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Oliveira AL; de Souza M; Carvalho-Dias VM; Ruiz MA; Silla L; Tanaka PY; Simões BP; Trabasso P; Seber A; Lotfi CJ; Zanichelli MA; Araujo VR; Godoy C; Maiolino A; Urakawa P; Cunha CA; de Souza CA; Pasquini R; Nucci M Bone Marrow Transplant; 2007 Jun; 39(12):775-81. PubMed ID: 17438585 [TBL] [Abstract][Full Text] [Related]
29. Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals. Fitzpatrick JM; Biswas JS; Edgeworth JD; Islam J; Jenkins N; Judge R; Lavery AJ; Melzer M; Morris-Jones S; Nsutebu EF; Peters J; Pillay DG; Pink F; Price JR; Scarborough M; Thwaites GE; Tilley R; Walker AS; Llewelyn MJ; Clin Microbiol Infect; 2016 Mar; 22(3):244-51. PubMed ID: 26577143 [TBL] [Abstract][Full Text] [Related]
30. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit. Cordero L; Rau R; Taylor D; Ayers LW Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611 [TBL] [Abstract][Full Text] [Related]
31. Antibiotic resistance of gram-negative bacilli isolated from pediatric patients with nosocomial bloodstream infections in a Mexican tertiary care hospital. Ares MÁ; Alcántar-Curiel MD; Jiménez-Galicia C; Rios-Sarabia N; Pacheco S; De la Cruz MÁ Chemotherapy; 2013; 59(5):361-8. PubMed ID: 24821320 [TBL] [Abstract][Full Text] [Related]
32. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes. Sligl WI; Dragan T; Smith SW Int J Infect Dis; 2015 Aug; 37():129-34. PubMed ID: 26159847 [TBL] [Abstract][Full Text] [Related]
33. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients. De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269 [TBL] [Abstract][Full Text] [Related]
34. Combination therapy and monotherapy in the treatment of severe infection in the immunocompromised host. Gaya H Am J Med; 1986 Jun; 80(6B):149-55. PubMed ID: 3728525 [TBL] [Abstract][Full Text] [Related]
35. Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer. Wade JC; Standiford HC; Drusano GL; Johnson DE; Moody MR; Bustamante CI; Joshi JH; deJongh C; Schimpff SC Am J Med; 1985 Jun; 78(6A):62-72. PubMed ID: 3859217 [TBL] [Abstract][Full Text] [Related]
36. [Gram-negative bacteremia in neutropenic patients with hematologic disorders. Experiences with prophylactic use of fluoroquinolones]. Sinkó J; Cser V; Konkoly Thege M; Masszi T Orv Hetil; 2011 Jul; 152(27):1063-7. PubMed ID: 21676672 [TBL] [Abstract][Full Text] [Related]
37. Overview of empiric antibiotic therapy for the febrile neutropenic patient. Schimpff SC Rev Infect Dis; 1985; 7 Suppl 4():S734-40. PubMed ID: 3878564 [TBL] [Abstract][Full Text] [Related]
38. Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer. A trial of oral penicillin V or placebo combined with pefloxacin. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. JAMA; 1994 Oct; 272(15):1183-9. PubMed ID: 7933348 [TBL] [Abstract][Full Text] [Related]